Aytu Biopharma (AYTU) Income towards Parent Company (2010 - 2025)
Aytu Biopharma (AYTU) reported Income towards Parent Company of $62000.0 for Q2 2025, up 105.0% year-over-year from $30243.3 in Q2 2024, and up 14.81% quarter-over-quarter from $54000.0 in Q1 2025.
Aytu Biopharma (AYTU) Income towards Parent Company (2010 - 2025) Analysis & Trends
Aytu Biopharma (AYTU) has 16 years of Income towards Parent Company data on file, last reported at $62000.0 in Q2 2025.
- Income towards Parent Company for Q2 2025 came in at $62000.0, up 105.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $62000.0 (up 109.1% YoY), and the FY2025 annual result was $620000.0, up 118.65% from the prior year.
- Income towards Parent Company improved to $62000.0 in Q2 2025 per AYTU's latest filing, from $54000.0 in the prior quarter.
- Over five years, Income towards Parent Company peaked at $381000.0 in Q3 2024 and troughed at -$53.3 million in Q1 2022.
- A 5-year average of -$8.7 million and a median of -$1.2 million in 2024 frame the typical range for Income towards Parent Company.
- The sharpest annual moves came in 2021 and 2024: Income towards Parent Company plunged 546.8% in 2021, then surged 158.89% in 2024.
- A 5-year view of Income towards Parent Company shows it stood at -$11.5 million in 2021, then soared by 42.04% to -$6.7 million in 2022, then jumped by 87.46% to -$839000.0 in 2023, then surged by 114.66% to $123000.0 in 2024, then slumped by 49.59% to $62000.0 in 2025.
- Business Quant data shows AYTU's Income towards Parent Company at $62000.0 in Q2 2025, $54000.0 in Q1 2025, and $123000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Aytu Biopharma | 23.76 Mn | -2.96 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 62,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 381,000.00 |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | -599,000.00 |
| Dec 31, 2023 | -839,000.00 |
| Sep 30, 2023 | -647,000.00 |
| Jun 30, 2023 | -2.58 Mn |
| Mar 31, 2023 | -7.20 Mn |
| Dec 31, 2022 | -6.69 Mn |
| Sep 30, 2022 | -701,000.00 |
| Jun 30, 2022 | -16.09 Mn |
| Mar 31, 2022 | -53.29 Mn |
| Dec 31, 2021 | -11.55 Mn |
| Sep 30, 2021 | -27.85 Mn |
| Jun 30, 2021 | -18.74 Mn |
| Dec 31, 2020 | -9.53 Mn |
| Sep 30, 2020 | -4.31 Mn |
| Jun 30, 2020 | -8.06 Mn |